CPC A61K 31/40 (2013.01) [A61K 31/454 (2013.01); A61K 31/4515 (2013.01); A61P 31/14 (2018.01)] | 7 Claims |
1. A method of treating COVID-19 in a patient in need thereof, said method comprising the step of administering a pharmaceutical composition comprising bepridil to the patient, wherein the pharmaceutical composition provides inhibition of severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) main protease (MPro).
|